Current Report · Items 1.01, 9.01 · 8-K

DSS, Inc.

DSSNYSE_AMERICANEQUITYCurrent

Entry into a Material Definitive Agreement

Filed Sep 21, 2026Accepted Sep 21, 2026, 4:05 PM EDTCIK 771999Accession 0001493152-26-043561

Company context

DSS, Inc. (together with its consolidated subsidiaries, referred to herein as “DSS,” “we,” “us,” “our,” or the “Company”) is a multi-segment operating company focused on packaging, biotechnology, financial services, and investment platform businesses. The Company operates through four principal business segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Through these segments, the Company seeks to develop and operate businesses across industries where management believes opportunities exist to create long-term shareholder value through operational growth, strategic partnerships, and the development or acquisition of complementary business platforms.

Current securities

DSSNYSE_AMERICAN · EQUITY · Current

Recent company filings

Registered securities in this filing

DSS, INC. · 8-K · Filed 2026-09-21

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $0.02 par value per share

Symbol: DSS
Exchange: NYSE
Classification: COMMON
Status: Current

Filing context

Context: AsOf2026-09-15

Dimensions: Not supplied

Accession 000149315226043561 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 1.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement

Item 1.01 Entry into a Material Definitive Agreement. Securities Purchase Agreement with Alset Inc. On September 15, 2026, DSS, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with Alset Inc., a Texas corporation (“Alset”), pursuant to which Alset has loaned the Company $500,000, in exchange for a convertible promissory note (the “Note”) and warrants to purchase 8,000,000 shares of the Company’s common stock (the “Warrants”). The Note, SPA, and Warrants are collectively referred to herein as the “Transaction Documents.” The Note is payable upon demand. The Note bears simple interest at 3% per annum. Alset may convert any outstanding principal and interest into shares of the Company’s common stock at $0.50 per share upon notice prior to maturity of the Note, which is five (5) years from the date thereof. The Warrants are to purchase up to 8,000,000 shares of the Company’s common stock at an exercise price of $0.55 per share. The Warrants expire on their fifth anniversary. The Transaction Documents will require the approval of the Company’s stockholders prior to the conversion of the Note or exercise of the Warrants. Alset holds a significant equity interest in the Company directly and through its subsidiaries. The Company and Alset are related parties under the common control of the Company’s Chairman, Chan Heng Fai, who is also the Chairman and Chief Executive Officer of Alset. Chan Tung Moe, a director and Co-Chief Executive Officer of Alset, is also a director of the Company. Lim Sheng Hon Danny, a director and officer of Alset, is also a director of the Company. Three of the Company’s independent directors, Joanne Wong Hiu Pan, Wong Shui Yeung, and William Wu, are also directors of Alset. The Transaction Documents were approved by the Company’s Board of Directors and Audit Committee. The foregoing is a summary only and does not purport to be complete. It is qualified in its entirety by reference to the Transaction Documents, copies of which are filed as Exhibits 10.1, 10.2, and 10.3 hereto and incorporated by reference herein.